Natera, Inc.(NTRA) - Stock detail

Natera, Inc.

US
NTRA
Natera, Inc.(Listing date: 07/02/2015)

Natera, Inc. was incorporated in Delaware in January 2007. The company is a diagnostic company with proprietary molecular and bioinformatics technologies that it is applying to transform disease management worldwide. The company's cell-free DNA (cfDNA) technology combines novel molecular analytical methods that can reliably measure many informative regions across the entire genome from samples as small as a single cell, as well as statistical algorithms that incorporate data provided by the broader scientific community to identify genetic variations covering a wide range of serious diseases with high precision and high coverage. The company's goal is to make personalized genetic testing and diagnosis part of the standard of care for protecting health and inform earlier and more targeted interventions to help achieve longer, healthier lives.

AI Technical AnalystHold
Rating4/10
Generated at:2026-05-07 17:41:29
Analysis based on data from the US Stock Market for Natera, Inc. (NTRA). Data analysis period: 2026-01-08 to 2026-05-07 (120 calendar days, 38 trading days). Requested range was 60 trading days. Data includes price, volume, and calculated technical indicators (Moving Averages, MACD, RSI, Bollinger Bands, KDJ, ATR, Williams %R, CCI, ADX) and estimated chip distribution metrics.
Insight

Technical analysis shows a short-term bullish breakout with strong momentum but multiple overbought signals suggest the rally may be overextended and due for a pullback.

Resistance
256.36
Support
172.82
Support and resistance are estimated from the latest 60 sessions.
Strategy
  • Short-term:For existing holders: hold positions but consider tightening stop-loss orders just below the key support confluence at $206 to protect profits. For potential buyers: wait for a pullback towards the $206-$208 support zone for a better risk-adjusted entry point, as current overbought conditions make the risk/reward unfavorable.
  • Mid-term:Monitor whether the price can sustain above the $218-$221 resistance area. A successful consolidation above support levels would signal stronger potential for a sustained uptrend. The next few trading sessions are critical for trend confirmation.
  • Long-term:Await clearer trend establishment indicated by a higher ADX and sustained price action above key resistance levels. The broad chip distribution and high volatility necessitate careful position sizing and ongoing monitoring of trend strength indicators.

Moving averages

MA 5
208.61
MA 20
206.22
MA 60
212.18
Price
219.82
AI Analysis
  • The simple moving averages show a short-term bullish alignment.
  • The 5-day MA ($208.61) is above both the 10-day ($206.85) and 20-day ($206.22) averages, indicating recent positive momentum.
  • The 60-day MA ($212.18) remains above all shorter-term averages, suggesting the longer-term trend from the past two months is still slightly bearish or consolidating.
  • The exponential moving averages confirm short-term strength: EMA_5 ($211.11) > EMA_10 ($208.53) > EMA_20 ($207.48).

Volume

Volume
2.52M
20D Avg
1.35M
Institution
-
Participation
-
AI Analysis
  • Volume has been a critical confirming factor.
  • The decline in late March and April was accompanied by high volume on down days, indicating strong selling pressure.
  • The recent rally, culminating in the 2026-05-07 surge, was accompanied by the highest single-day volume in the dataset (2.52 million shares).
  • This 'volume confirmation' significantly strengthens the validity of the current bullish breakout.

MACD

MACD
0.10
Signal
-1.68
Hist
1.77
Trend
-
AI Analysis
  • The MACD line (0.4174) is above the signal line (-1.2020), resulting in a positive MACD histogram value of 1.6193.
  • This is a bullish crossover signal, indicating that positive momentum is building.
  • The histogram's positive value shows the bullish momentum is currently expanding.

Bollinger bands

Upper
218.16
Middle
206.22
Lower
194.28
Width
11.58%
AI Analysis
  • The latest closing price of $219.82 is positioned above the upper Bollinger Band ($218.16).
  • A close above the upper band often suggests the stock is overbought in the short term and may be due for a consolidation or pullback towards the middle band ($206.22).
  • The width of the bands (Upper - Lower = $23.88) indicates moderate volatility.

RSI

RSI(14)
57.22
RSI(6)
66.75
Overbought
70+
Oversold
30-
AI Analysis
  • The 14-period RSI stands at 57.25.
  • This value is in neutral territory, leaning slightly towards bullish but not yet in overbought conditions.
  • The more sensitive 6-period RSI is higher at 66.75, indicating stronger recent buying pressure and approaching overbought levels, which warrants caution for a potential short-term pullback.

KDJ

K
70.90
D
61.37
J
89.95
Trend
-
AI Analysis
  • The KDJ values (K: 70.90, D: 61.37, J: 89.95) show a bullish configuration.
  • The J-line at 89.95 is deep in overbought territory (>80).
  • The K-line crossing above the D-line supports the short-term bullish momentum.
  • The high J-value reinforces the overbought signal from the Bollinger Bands.

Chip distribution

How chip distribution helps you?
Chip distribution summary
  • Current price is testing the upper bound of the 70% cost concentration range, suggesting a major area of potential supply/resistance from holders who bought near these levels.
  • The estimated chip distribution data provides context for market psychology.
  • With a profit ratio of 85.94%, the vast majority of recent traders are currently in a profitable position.
  • This can create a 'floating supply' of shares that may be sold to realize profits, potentially capping upward moves.
  • The average cost is estimated at $173.73, well below the current price, reinforcing the high profit ratio.
  • The 70% cost concentration range of [$150.87, $216.80] shows that a significant majority of chips are held between these levels.
  • The current price is at the very top of this range, suggesting it is testing a major area of potential supply (resistance) from holders who bought near these levels.
  • The 90% concentration range is wide ([$138.57, $236.14]), indicating a broad distribution of holder costs.
No chart data

Data is estimated based on turnover rate, high, low, open, and close prices. Profit ratios may vary significantly across different brokerage tools.